Hyperthermia is an additional method of treatment used in the therapy of solid tumors. The Greater Poland Cancer Centre uses the Celsius 42+ apparatus to carry out locoregional hyperthermia treatments. The study was conducted on 20 patients with cervical cancer. Treatments were performed 1-2 times a week, in the scheme of hyperthermia - maximum one hour break - radiotherapy, in accordance with the manufacturer's recommendations. It seems that the assessment of the comfort of treatment in oncological patients is extremely important, both for patients and for the development of medicine. During the study, four main problems emerged during the hyperthermia treatment, depending on the number of sessions or BMI of the patient.
Rzepka E, Puskulluoglu Miroslawa Znaczenie hipertermii w leczeniu onkologicznym. ViaMedica 2015
Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002; 3(8):487–497.
Alexander HR. Isolation perfusion. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Critical Reviews in Oncology/Hematology 2002; 43(1):33–56.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.